Management ChangeAug 2, 2026, 07:31 PM
Ascentage Pharma Appoints Faiçal Miyara as CBO, Jim Ziegler as CCO
AI Summary
Ascentage Pharma Group International has announced two key executive appointments to bolster its global expansion. Dr. Faiçal Miyara has been named Chief Business Officer, responsible for global business development, while Jim Ziegler has been appointed Chief Commercial Officer, overseeing commercialization in the US and other markets outside China. Both will report to the CEO and bring extensive experience to strengthen the company's capabilities as it advances multiple global registrational Phase III studies.
Key Highlights
- Faiçal Miyara, PhD, appointed as Chief Business Officer (CBO).
- Jim Ziegler appointed as Chief Commercial Officer (CCO).
- Dr. Miyara will lead global business development.
- Mr. Ziegler will lead US and ex-China commercialization.
- Both executives will report directly to Dr. Dajun Yang, Chairman and CEO.
- Dr. Miyara brings over 20 years of oncology business development experience.
- Mr. Ziegler has over 25 years of commercial and operational leadership in biopharma.
Price Impact
More from AAPG